Agilent Technologies (NYSE:A) Releases FY 2026 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 6.180-6.210 for the period, compared to the consensus earnings per share estimate of 6.060. The company issued revenue guidance of $7.5 billion-$7.5 billion, compared to the consensus revenue estimate of $7.4 billion. Agilent Technologies also updated its Q4 2026 guidance to 1.710-1.740 EPS.

Agilent Technologies Stock Up 0.3%

NYSE A traded up $0.39 during mid-day trading on Wednesday, reaching $155.16. 3,131,622 shares of the company’s stock traded hands, compared to its average volume of 2,234,282. Agilent Technologies has a 1-year low of $108.35 and a 1-year high of $160.51. The company has a market cap of $43.82 billion, a price-to-earnings ratio of 31.16, a P/E/G ratio of 2.71 and a beta of 1.25. The company has a fifty day simple moving average of $138.55 and a 200-day simple moving average of $126.47. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities research analysts expect that Agilent Technologies will post 6.05 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Piper Sandler assumed coverage on Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective for the company. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 2nd. Wolfe Research reissued a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Barclays boosted their target price on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Finally, Jefferies Financial Group started coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price target on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $160.24.

Institutional Investors Weigh In On Agilent Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. State of Wyoming acquired a new position in Agilent Technologies in the second quarter worth about $35,000. Transamerica Financial Advisors LLC raised its stake in shares of Agilent Technologies by 180.8% in the fourth quarter. Transamerica Financial Advisors LLC now owns 337 shares of the medical research company’s stock valued at $46,000 after acquiring an additional 217 shares during the last quarter. Johnson Financial Group Inc. acquired a new position in shares of Agilent Technologies in the 3rd quarter worth approximately $49,000. DV Equities LLC bought a new stake in Agilent Technologies during the 4th quarter worth approximately $54,000. Finally, Itau Unibanco Holding S.A. bought a new stake in Agilent Technologies during the 4th quarter worth approximately $58,000.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.